It has been reported that targeting STAT3 affected cell proliferation and migration in cancer cells [30,31], and activation of JAK/STAT3 signaling pathway via enhancing EMT increases tumorigenic and metastatic ability and chemoresistance in cancer cells [32]. This evidence concerns the gene STAT3 and cancer.